MiniMed：新一代糖尿病平台支撐「買進」評級 (NASDAQ:MMED)
· seekingalpha.com
MiniMed 的雙位數營收成長受惠於強勁的國際採用率、持續擴張的連續血糖監測 (CGM) 市場以及及時的產品發布。深入了解為何 MMED 股票值得買進。
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...